跳至主要内容
临床试验/NCT02901652
NCT02901652Unknown不适用

Comparison of Nasal Intermittent Positive Airway Pressure and Nasal Bi-level Positive Airway Pressure Methods in Preterm Infants With Respiratory Distress Syndrome With Gestational Age of 26-30 Weeks

Zekai Tahir Burak Women's Health Research and Education Hospital2 个研究点 分布在 1 个国家目标入组 325 人开始时间: 2016年9月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
发起方
入组人数
325
试验地点
2
主要终点
surfactant requirement

研究概览

简要总结

Purpose is to compare introduction of NIPPV (Nasal Intermittent Positive-Pressure Ventilation) and nBiPAP (Nasal Bi-level Positive Airway Pressure) in terms of mechanical ventilation (MV) need (non-invasive respiratory support failure) and surfactant need within the first 72 hours of life in preterm infants with Respiratory Distress Syndrome (RDS) at 26-30 weeks of gestation.

详细描述

Purpose is to compare introduction of NIPPV and nBiPAP in terms of mechanical ventilation (MV) need (non-invasive respiratory support failure) and surfactant need within the first 72 hours of life in preterm infants with Respiratory Distress Syndrome (RDS) at 26-30 weeks of gestation.

Method

Primary Outcome Measures:

In NIPPV and BIPAP groups, comparison of mechanical ventilation (MV) need (non-invasive respiratory support failure) and surfactant need within the first 72 hours of life

Secondary Outcome Measures:

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
1 Hour 至 3 Days(Child)
性别
All
接受健康志愿者

入选标准

  • Preterm infant with gestational age of 26 weeks 0 days and 29 weeks 6 days will be included.

排除标准

  • Major congenital anomalies
  • Presence of cardiovascular instability
  • Intubation at admission to the NICU
  • Consent not provided or refused

研究组 & 干预措施

NIPPV

Active Comparator

noninvasive respiratory support devices

This group receiving Nasal Intermittent Positive Pressure Ventilation (NIPPV) treatment.

干预措施: noninvasive respiratory support devices (Device)

BİPAP

Active Comparator

noninvasive respiratory support devices

This group receive Bi-Level Positive Airway Pressure (BIPAP) treatment.

干预措施: noninvasive respiratory support devices (Device)

结局指标

主要结局

surfactant requirement

时间窗: 72 HOURS

surfactant requirement within the first 72 hours of life

次要结局

未报告次要终点

研究者

发起方
Zekai Tahir Burak Women's Health Research and Education Hospital
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验